Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF‐α and IL‐1 β

Migration from sites of antigen encounter to lymphoid organs is essential to the strong immunogenic function of dendritic cells (DC). In the skin, migration proceeds through dermal lymphatic vessels and is regulated in an incompletely understood way by inflammatory mediators. We studied the effects of tumor necrosis factor α (TNF‐α) and interleukin‐1β (IL‐1β) in mouse skin organ cultures by direct enumeration of migrating DC and by immunohistochemistry. (1) Neutralizing antibodies to TNF‐α and IL‐1β inhibited migration of DC, also in human skin explants (TNF‐α). (2) TNF‐α at low concentrations (50 U/mL) and IL‐1β (50–3000 U/mL) augmented migration to about 150% of spontaneous migration. (3) High concentrations of TNF‐α (5000 U/mL) inhibited migration by approximately 50%. (4) DC migration from skin explants of TNF‐α/lymphotoxin‐α double‐deficient mice and TNF‐receptor type 1 and 2 double knock‐out mice was not impaired. (5) TNF‐α effects were neutralized by anti‐IL‐1β, and vice versa. We conclude that in normal animals both TNF‐α and IL‐1 β are required for DC migration to occur. In the complete absence of one cytokine (TNF‐α), however, backup mechanisms step in. J. Leukoc. Biol. 66: 462–470; 1999.

[1]  S. Hudak,et al.  The CC Chemokine Receptor-7 Ligands 6Ckine and Macrophage Inflammatory Protein-3β Are Potent Chemoattractants for In Vitro- and In Vivo-Derived Dendritic Cells , 1999, The Journal of Immunology.

[2]  H. Saeki,et al.  Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. , 1999, Journal of immunology.

[3]  S. Hudak,et al.  The CC Chemokine Receptor-7 Ligands 6Ckine and Macrophage Inflammatory Protein-3b Are Potent Chemoattractants for In Vitro- and In Vivo-Derived Dendritic Cells , 1999 .

[4]  C. Caux,et al.  Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites , 1998, The Journal of experimental medicine.

[5]  R. Steinman,et al.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Masatoshi Suzuki,et al.  Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.

[7]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[8]  Jonathan M. Austyn,et al.  Dendritic cells , 1998, Current opinion in hematology.

[9]  T. Mak,et al.  Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. , 1997, Journal of immunology.

[10]  I. Kimber,et al.  α6 Integrins Are Required for Langerhans Cell Migration from the Epidermis , 1997, The Journal of experimental medicine.

[11]  I. Kimber,et al.  Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration , 1997, Immunology.

[12]  P. Morrissey,et al.  Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. , 1997, Journal of immunology.

[13]  K. McIntyre,et al.  Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. , 1997, Journal of immunology.

[14]  L. Steinman Some Misconceptions about Understanding Autoimmunity through Experiments with Knockouts , 1997, The Journal of experimental medicine.

[15]  J. Sleeman,et al.  An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function , 1997, The Journal of cell biology.

[16]  R. Steinman,et al.  Dendritic cells in the T‐cell areas of lymphoid organs , 1997, Immunological reviews.

[17]  P. De Baetselier,et al.  Regulation of Dendritic Cell Numbers and Maturation by Lipopolysaccharide in Vivo , 1996 .

[18]  G. Schuler,et al.  An improved isolation method for murine migratory cutaneous dendritic cells. , 1996, Journal of immunological methods.

[19]  R. Karr,et al.  Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone , 1996, The Journal of experimental medicine.

[20]  J. Austyn New insights into the mobilization and phagocytic activity of dendritic cells , 1996, The Journal of experimental medicine.

[21]  M. Udey,et al.  Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. , 1996, The Journal of investigative dermatology.

[22]  P. Das,et al.  Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[23]  Rolf M. Zinkernagel,et al.  Immunology Taught by Viruses , 1996, Science.

[24]  R. Zinkernagel,et al.  Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice , 1996 .

[25]  R. Karr,et al.  Mice Deficient in ILI ~ Manifest Impaired Contact Hypersensitivity to Trinitrochlorobenzene , 2003 .

[26]  T. Mak,et al.  Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. , 1995, Journal of immunology.

[27]  P. Morris,et al.  Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 , 1995, The Journal of experimental medicine.

[28]  I. Kimber,et al.  Langerhans Cell Migration: Initiation and Regulation , 1995 .

[29]  R. Steinman,et al.  Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. , 1995, The Journal of investigative dermatology.

[30]  V. McFarland,et al.  Expression of E‐cadherin by murine dendritic cells: E‐cadherin as a dendritic cell differentiation antigen characteristic of epidermal Langerhans cells and related cells , 1994, European journal of immunology.

[31]  I. Kimber,et al.  Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. , 1994, Immunology.

[32]  G. Schuler,et al.  Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. , 1993, The Journal of clinical investigation.

[33]  R. Zinkernagel,et al.  Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.

[34]  A. Enk,et al.  An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. , 1993, Journal of immunology.

[35]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Dallman,et al.  Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction , 1991, The Journal of experimental medicine.

[37]  B. Echtenacher,et al.  Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. , 1990, Journal of immunology.

[38]  R. Steinman,et al.  Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.

[39]  C. Bucana,et al.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. , 1990, Journal of immunology.

[40]  P. Morris,et al.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection , 1990, The Journal of experimental medicine.

[41]  G. Schuler,et al.  Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation , 1990, The Journal of experimental medicine.

[42]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[43]  P. Botham,et al.  Control of the immune response to contact sensitizing chemicals by cutaneous antigen‐presenting cells , 1987, The British journal of dermatology.

[44]  Y. Horiguchi,et al.  A monoclonal antibody specifically reactive to human Langerhans cells. , 1986, The Journal of investigative dermatology.

[45]  G. Kraal,et al.  Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody , 1986, The Journal of experimental medicine.

[46]  G. Toews,et al.  Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization. , 1980, The Journal of investigative dermatology.

[47]  W. Shelley,et al.  New staining techniques for the Langerhans cell. , 1977, Acta dermato-venereologica.